![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1552540 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of ATPIF1 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1552540 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATPIF1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | ISO | RGD:1312589 | 6480464 | Estradiol results in decreased expression of ATP5IF1 mRNA | CTD | PMID:23019147 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | RGD:1552540 | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1552540 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATPIF1 mRNA | CTD | PMID:28213091 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ATP5IF1 mRNA | CTD | PMID:34747641 | 2,4,6-trinitrotoluene | affects expression | EXP | | 6480464 | Trinitrotoluene affects the expression of ATPIF1 mRNA | CTD | PMID:21346803 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 4-dinitrotoluene affects the expression of ATPIF1 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 6-dinitrotoluene affects the expression of ATPIF1 mRNA | CTD | PMID:21346803 | 2-butoxyethanol | increases expression | ISO | RGD:1552540 | 6480464 | n-butoxyethanol results in increased expression of ATPIF1 mRNA | CTD | PMID:19812364 | 2-hydroxypropanoic acid | decreases expression | ISO | RGD:1312589 | 6480464 | Lactic Acid results in decreased expression of ATPIF1 mRNA | CTD | PMID:30851411 | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23196670 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:1552540 | 6480464 | 4, 4'-diaminodiphenylmethane results in decreased expression of ATPIF1 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | RGD:1312589 | 6480464 | [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of ATP5IF1 gene | CTD | PMID:31601247 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1552540 | 6480464 | Fenretinide results in increased expression of ATPIF1 mRNA | CTD | PMID:28973697 | 5-aza-2'-deoxycytidine | affects expression | ISO | RGD:1312589 | 6480464 | Decitabine affects the expression of ATP5IF1 mRNA | CTD | PMID:23300844 | 7,12-dimethyltetraphene | increases expression | EXP | | 6480464 | 9 more ... | CTD | PMID:12376462 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of ATP5IF1 mRNA | CTD | PMID:31881176 | acrylamide | affects expression | EXP | | 6480464 | Acrylamide affects the expression of ATPIF1 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of ATP5IF1 mRNA, Aflatoxin B1 results in increased expression of ATPIF1 mRNA | CTD | PMID:23630614 more ... | all-trans-retinoic acid | multiple interactions | ISO | RGD:1312589 | 6480464 | [IFNB1 protein co-treated with Tretinoin] results in increased expression of ATP5IF1 protein | CTD | PMID:16826196 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ATPIF1 mRNA | CTD | PMID:16483693 | arsenite(3-) | multiple interactions | ISO | RGD:1312589 | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to ATP5IF1 mRNA] | CTD | PMID:32406909 | arsenous acid | decreases expression | ISO | RGD:1552540 | 6480464 | Arsenic Trioxide results in decreased expression of ATPIF1 mRNA | CTD | PMID:19422848 | arsenous acid | increases expression | ISO | RGD:1312589 | 6480464 | Arsenic Trioxide results in increased expression of ATP5IF1 mRNA | CTD | PMID:20458559 | benzo[a]pyrene | increases expression | ISO | RGD:1552540 | 6480464 | Benzo(a)pyrene results in increased expression of ATPIF1 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | multiple interactions | ISO | RGD:1552540 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ATPIF1 mRNA] | CTD | PMID:22228805 | bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1552540 | 6480464 | Diethylhexyl Phthalate results in increased expression of ATPIF1 mRNA | CTD | PMID:19850644 | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:1552540 | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ATPIF1 mRNA] | CTD | PMID:19850644 | bisphenol A | decreases expression | ISO | RGD:1312589 | 6480464 | bisphenol A results in decreased expression of ATPIF1 mRNA | CTD | PMID:29275510 | bisphenol A | decreases methylation | ISO | RGD:1312589 | 6480464 | bisphenol A results in decreased methylation of ATP5IF1 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | RGD:1552540 | 6480464 | bisphenol A results in decreased expression of ATPIF1 mRNA | CTD | PMID:33221593 | bisphenol A | affects expression | ISO | RGD:1312589 | 6480464 | bisphenol A affects the expression of ATPIF1 mRNA | CTD | PMID:30903817 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ATPIF1 mRNA | CTD | PMID:25181051 | Bisphenol B | increases expression | ISO | RGD:1312589 | 6480464 | bisphenol B results in increased expression of ATP5IF1 protein | CTD | PMID:34186270 | bleomycin A2 | increases expression | EXP | | 6480464 | Bleomycin results in increased expression of ATPIF1 protein | CTD | PMID:25933445 | carbon nanotube | decreases expression | ISO | RGD:1552540 | 6480464 | Nanotubes more ... | CTD | PMID:25554681, PMID:25620056 | choline | multiple interactions | ISO | RGD:1552540 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATPIF1 mRNA | CTD | PMID:20938992 | cisplatin | affects expression | ISO | RGD:1312589 | 6480464 | Cisplatin affects the expression of ATP5IF1 mRNA | CTD | PMID:23300844 | copper(II) sulfate | decreases expression | ISO | RGD:1312589 | 6480464 | Copper Sulfate results in decreased expression of ATP5IF1 mRNA | CTD | PMID:19549813 | coumarin | increases expression | EXP | | 6480464 | coumarin results in increased expression of ATPIF1 mRNA | CTD | PMID:18480146 | cyclosporin A | decreases expression | ISO | RGD:1312589 | 6480464 | Cyclosporine results in decreased expression of ATP5IF1 mRNA | CTD | PMID:20106945, PMID:25562108 | diarsenic trioxide | increases expression | ISO | RGD:1312589 | 6480464 | Arsenic Trioxide results in increased expression of ATP5IF1 mRNA | CTD | PMID:20458559 | diarsenic trioxide | decreases expression | ISO | RGD:1552540 | 6480464 | Arsenic Trioxide results in decreased expression of ATPIF1 mRNA | CTD | PMID:19422848 | diazinon | increases methylation | ISO | RGD:1312589 | 6480464 | Diazinon results in increased methylation of ATP5IF1 gene | CTD | PMID:22964155 | dibutyl phthalate | increases expression | ISO | RGD:1552540 | 6480464 | Dibutyl Phthalate results in increased expression of ATPIF1 mRNA | CTD | PMID:17361019, PMID:21266533 | dorsomorphin | multiple interactions | ISO | RGD:1312589 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP5IF1 mRNA | CTD | PMID:27188386 | doxorubicin | increases expression | ISO | RGD:1552540 | 6480464 | Doxorubicin results in increased expression of ATPIF1 mRNA | CTD | PMID:26873546 | doxorubicin | decreases expression | ISO | RGD:1312589 | 6480464 | Doxorubicin results in decreased expression of ATP5IF1 mRNA | CTD | PMID:29803840 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of ATP5IF1 mRNA | CTD | PMID:29391264 | ethanol | affects expression | ISO | RGD:1552540 | 6480464 | Ethanol affects the expression of ATPIF1 mRNA | CTD | PMID:30319688 | ethanol | increases expression | ISO | RGD:1552540 | 6480464 | Ethanol results in increased expression of ATPIF1 mRNA | CTD | PMID:30319688 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of ATPIF1 mRNA | CTD | PMID:24136188 | fipronil | increases expression | EXP | | 6480464 | fipronil results in increased expression of ATP5IF1 mRNA | CTD | PMID:31881178 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of ATPIF1 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | RGD:1552540 | 6480464 | [1 more ... | CTD | PMID:20938992, PMID:22206623 | fulvestrant | multiple interactions | ISO | RGD:1312589 | 6480464 | [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of ATP5IF1 gene | CTD | PMID:31601247 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of ATPIF1 mRNA | CTD | PMID:26194646 | gamma-hexachlorocyclohexane | decreases expression | EXP | | 6480464 | Hexachlorocyclohexane results in decreased expression of ATPIF1 mRNA | CTD | PMID:17785943 | hydrazine | decreases expression | EXP | | 6480464 | hydrazine results in decreased expression of ATPIF1 mRNA | CTD | PMID:15370871 | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of ATPIF1 mRNA | CTD | PMID:21396975 | ivermectin | decreases expression | ISO | RGD:1312589 | 6480464 | Ivermectin results in decreased expression of ATP5IF1 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | ISO | RGD:1552540 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATPIF1 mRNA | CTD | PMID:20938992 | lipopolysaccharide | multiple interactions | ISO | RGD:1312589 | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATPIF1 mRNA | CTD | PMID:31059760 | lipopolysaccharide | decreases expression | ISO | RGD:1312589 | 6480464 | Lipopolysaccharides results in decreased expression of ATPIF1 mRNA | CTD | PMID:31059760 | menadione | affects expression | ISO | RGD:1312589 | 6480464 | Vitamin K 3 affects the expression of ATP5IF1 mRNA | CTD | PMID:20044591 | methylmercury(1+) | increases expression | EXP | | 6480464 | methylmercury II results in increased expression of ATPIF1 mRNA | CTD | PMID:17905399 | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of ATPIF1 mRNA | CTD | PMID:19638242 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ATPIF1 mRNA more ... | CTD | PMID:25374375, PMID:28943392 | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of ATPIF1 mRNA | CTD | PMID:24136188 | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of ATPIF1 mRNA | CTD | PMID:24136188 | ozone | multiple interactions | ISO | RGD:1552540 | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ATPIF1 mRNA | CTD | PMID:34911549 | p-toluidine | increases expression | EXP | | 6480464 | 4-toluidine results in increased expression of ATPIF1 mRNA | CTD | PMID:27638505 | paracetamol | decreases expression | ISO | RGD:1312589 | 6480464 | Acetaminophen results in decreased expression of ATP5IF1 mRNA, Acetaminophen results in decreased expression of ATPIF1 mRNA | CTD | PMID:25704631, PMID:31059760 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ATP5IF1 mRNA | CTD | PMID:33387578 | paracetamol | multiple interactions | ISO | RGD:1312589 | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATPIF1 mRNA | CTD | PMID:31059760 | perfluorononanoic acid | decreases expression | ISO | RGD:1312589 | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of ATP5IF1 mRNA | CTD | PMID:32588087 | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of ATPIF1 mRNA | CTD | PMID:19162173 | phenobarbital | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ATPIF1 mRNA, [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ATPIF1 promoter | CTD | PMID:25374375 | phenylmercury acetate | increases expression | ISO | RGD:1312589 | 6480464 | Phenylmercuric Acetate results in increased expression of ATP5IF1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1312589 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP5IF1 mRNA | CTD | PMID:27188386 | PhIP | increases expression | EXP | | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of ATPIF1 mRNA | CTD | PMID:12376462 | pirinixic acid | decreases expression | ISO | RGD:1552540 | 6480464 | pirinixic acid results in decreased expression of ATPIF1 mRNA | CTD | PMID:18445702 | pirinixic acid | affects expression | ISO | RGD:1552540 | 6480464 | pirinixic acid affects the expression of ATPIF1 mRNA | CTD | PMID:23811191 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of ATPIF1 mRNA | CTD | PMID:19162173 | pirinixic acid | multiple interactions | ISO | RGD:1552540 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ATPIF1 mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of ATPIF1 mRNA] | CTD | PMID:19710929, PMID:20059764 | pirinixic acid | increases expression | ISO | RGD:1552540 | 6480464 | pirinixic acid results in increased expression of ATPIF1 mRNA | CTD | PMID:18301758, PMID:20059764 | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of ATPIF1 mRNA | CTD | PMID:19162173 | rac-lactic acid | decreases expression | ISO | RGD:1312589 | 6480464 | Lactic Acid results in decreased expression of ATPIF1 mRNA | CTD | PMID:30851411 | resveratrol | decreases expression | ISO | RGD:1552540 | 6480464 | resveratrol results in decreased expression of ATPIF1 protein | CTD | PMID:25505154 | SB 431542 | multiple interactions | ISO | RGD:1312589 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP5IF1 mRNA | CTD | PMID:27188386 | senecionine | decreases expression | ISO | RGD:1552540 | 6480464 | senecionine results in decreased expression of ATP5IF1 protein | CTD | PMID:35357534 | testosterone | multiple interactions | ISO | RGD:1552540 | 6480464 | 1 more ... | CTD | PMID:33848595 | testosterone | increases expression | ISO | RGD:1552540 | 6480464 | Testosterone deficiency results in increased expression of ATPIF1 mRNA | CTD | PMID:33848595 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of ATPIF1 mRNA | CTD | PMID:16239168 | tetrachloromethane | affects expression | ISO | RGD:1552540 | 6480464 | Carbon Tetrachloride affects the expression of ATPIF1 mRNA | CTD | PMID:31919559 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of ATP5IF1 mRNA | CTD | PMID:31150632 | thimerosal | decreases expression | ISO | RGD:1312589 | 6480464 | Thimerosal results in decreased expression of ATP5IF1 mRNA | CTD | PMID:27188386 | thioacetamide | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ATPIF1 mRNA | CTD | PMID:28943392 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of ATPIF1 mRNA | CTD | PMID:19448997 | troglitazone | decreases expression | ISO | RGD:1312589 | 6480464 | troglitazone results in decreased expression of ATP5IF1 mRNA | CTD | PMID:19140230 | tungsten | increases expression | ISO | RGD:1552540 | 6480464 | Tungsten results in increased expression of ATPIF1 mRNA | CTD | PMID:30912803 | urethane | increases expression | ISO | RGD:1552540 | 6480464 | Urethane results in increased expression of ATPIF1 mRNA | CTD | PMID:16289808 | valproic acid | increases methylation | ISO | RGD:1312589 | 6480464 | Valproic Acid results in increased methylation of ATPIF1 gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | RGD:1312589 | 6480464 | Valproic Acid results in increased expression of ATP5IF1 mRNA | CTD | PMID:23179753, PMID:27188386 | valproic acid | affects expression | ISO | RGD:1312589 | 6480464 | Valproic Acid affects the expression of ATP5IF1 mRNA | CTD | PMID:25979313 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of ATPIF1 mRNA | CTD | PMID:23034163 | |